Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  Genscript Biotech Corp    1548   KYG3825B1059

GENSCRIPT BIOTECH CORP (1548)
Mes dernières consult.
Most popular
Report
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Stock Exchange Of Hong Ko…
10/16/2017 10/17/2017 10/18/2017 10/19/2017 10/20/2017 Date
9.61 10.1 10.24 9.6 9.79 Last
33562876 11542782 9870000 60188000 7523000 Volume
-7.06% +5.10% +1.39% -6.25% +1.98% Change
Financials ( HKD)
Sales 2017 1 072 M
EBIT 2017 282 M
Net income 2017 224 M
Finance 2017 1 017 M
Yield 2017 -
Sales 2018 1 354 M
EBIT 2018 344 M
Net income 2018 277 M
Finance 2018 1 189 M
Yield 2018 -
P/E ratio 2017 71,77
P/E ratio 2018 64,45
EV / Sales2017 14,8x
EV / Sales2018 11,6x
Capitalization 16 924 M
More Financials
Company
Genscript Biotech Corp. engages in the provision of biological research service.It operates through the following segments: Life Science Research Services, Life Sciences Research Catalog Products, Preclinical Drug Development Services, and Industrial Synthetic Biology Products.The Life Science... 
Sector
Biotechnology & Medical Research
Calendar

- No events available -

More about the company
Surperformance© ratings of Genscript Biotech Corp
Trading Rating : - Investor Rating :
More Ratings
Latest news on GENSCRIPT BIOTECH CORP
10/19 GENSCRIPT BIOTECH : Bio directors transfer controlling holder's stake
09/19 GENSCRIPT BIOTECH : Bio reveals CAR-T cell technology R&D progress
07/25 GENSCRIPT BIOTECH : Launches Custom Rabbit Monoclonal Antibody Service
06/28 GENSCRIPT BIOTECH : Bio unit gets Rmb15.72m capital injection
05/29 GENSCRIPT BIOTECH : Bio new drug's clinical trial application accepted
05/15 GENSCRIPT BIOTECH : Bio CAR-T technology R&D yields promising results
03/18 GENSCRIPT BIOTECH : Bio terminates JV formation with China Resources
02/09 GENSCRIPT BIOTECH : Bio sees huge growth in annual net profit
2016 GENSCRIPT BIOTECH : Bio to form biotech R&D JV with China Resources
2016 GENSCRIPT BIOTECH : China Resources Medicine Team Up
More news
Sector news : Bio Diagnostics & Testing
10/18DJGILEAD SCIENCES : Cell-Therapy Drug Yescarta Gets FDA Approval -- Update
10/18DJGILEAD SCIENCES : Cell-Therapy Drug Yescarta Gets FDA Approval
10/18DJACTELION : J&J Net Income Falls After Actelion Deal -- WSJ
10/17 Regeneron-Sanofi drug succeeds mid-stage study
10/17DJJOHNSON & JOHNSON : Outlook Buoyed by Drug Unit -- Update
More sector news : Bio Diagnostics & Testing
Chart GENSCRIPT BIOTECH CORP
Duration : Period :
Genscript Biotech Corp Technical Analysis Chart | 1548 | KYG3825B1059 | 4-Traders
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Average target price 5,50  HKD
Spread / Average Target -44%
EPS Revisions
Managers
NameTitle
Fang Liang Zhang Chairman & Chief Executive Officer
Ye Wang Chief Operating Officer & Executive Director
Jian Ge Meng Executive Director & Vice President-Finance
Lu Quan Wang Non-Executive Director
Zuie Chin Huang Director
Sector and Competitors
1st jan.Capitalization (M$)
GENSCRIPT BIOTECH CORP164.59%2 169
MIRACA HOLDINGS INC.0.76%2 676
BEIJING STRONG BIOTECHNOLOGIES INC--.--%1 245
INNATE PHARMA-31.01%681
SEEGENE INC--.--%632
IOVANCE BIOTHERAPEUTICS INC3.96%508